Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 10 hours ago
Amgen lays groundwork for new R&D center in Hyderabad
about 10 hours ago
Amgen is expanding its footprint in India with an R&D center in...
Epicrispr raises $90M to rewrite treatment of rare muscle disease
about 13 hours ago
Epicrispr Biotechnologies has raised $90 million in a series C round backed...
Zydus’ Sentynl pens $475M deal for Mereo’s phase 3-ready rare genetic lung disease drug
about 14 hours ago
Sentynl Therapeutics has penned a deal potentially worth $475 million for the...
Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer
about 14 hours ago
Aura Biosciences is refocusing under its recently installed CEO, laying off 20%...
Abbott teams with Google Health on AI-powered health insights app
about 15 hours ago
Two giants of their respective fields, Abbott and Google, are joining forces...
Regeneron backs $75M series A for antibody upstart Infinimmune
about 16 hours ago
Infinimmune has amassed further fuel to power its antibody discovery engine, netting...
‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorder
about 17 hours ago
Vaderis Therapeutics has secured an oversubscribed $152 million series B financing to...
ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
1 day ago
The FDA has denied ITM Isotopes Technologies’ lead pipeline candidate for a...
MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial
1 day ago
MoonLake Immunotherapeutics announced positive phase 3 data of patients with psoriatic arthritis...
Jazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapies
1 day ago
Jazz Pharmaceuticals is adding to its orchestra of epilepsy treatments with the...
Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
1 day ago
Scholar Rock has dropped Novo Nordisk’s troubled Catalent facility as a contract...
Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for Vertex
1 day ago
Sionna Therapeutics has axed a cystic fibrosis add-on program after flunking a...